Gilead Sciences
GILD
#94
Rank
A$262.85 B
Marketcap
A$211.73
Share price
0.75%
Change (1 day)
15.16%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): A$15.32 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are A$29.08 Billion. In 2024 the company made an earning of A$0.97 Billion a decrease over its 2023 earnings that were of A$9.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$15.32 B1474.18%
2024 A$0.97 B-89.94%
2023 A$9.67 B17.97%
2022 A$8.20 B-29.77%
2021 A$11.68 B395.99%
2020 A$2.35 B-67.66%
2019 A$7.28 B-33.84%
2018 A$11.00 B-42.35%
2017 A$19.08 B-20.87%
2016 A$24.12 B-21.06%
2015 A$30.56 B45.8%
2014 A$20.96 B253.01%
2013 A$5.93 B16.51%
2012 A$5.09 B-1.07%
2011 A$5.15 B-6.71%
2010 A$5.52 B11.75%
2009 A$4.94 B29.5%
2008 A$3.81 B19.11%
2007 A$3.20 B-455.74%
2006 -A$0.91 Billion-154.93%
2005 A$1.63 B76.99%
2004 A$0.92 B-266.16%
2003 -A$0.56 Billion-638.24%
2002 A$0.10 B31.5%
2001 A$78.75 M-242.15%
2000 -A$55.41 Million-40.2%
1999 -A$92.65 Million31.85%
1998 -A$70.27 Million8.73%
1997 -A$64.63 Million27.22%
1996 -A$50.8 Million
1994 -A$48.4 Million26.57%
1993 -A$38.24 Million46.49%
1992 -A$26.11 Million362.5%
1991 -A$5.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.71 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$16.72 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.34 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$31.75 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.63 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.68 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.40 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.29 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$32.57 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA